Log In
BCIQ
Print this Print this
 

AIR DNase (PRX-110)

  Manage Alerts
Collapse Summary General Information
Company Protalix BioTherapeutics Inc.
DescriptionPlant cell-derived recombinant form of human deoxyribonuclease I (DNASE1) resistant to actin inhibition
Molecular Target Deoxyribonuclease I (DNASE1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today